Medical AI Diagnostic
Clinical Grade
Featured
AVIEW LCS Plus
Diagnostic Solution for Big 3 Chest Disease - Advanced AI-Powered Analysis for Lung Nodules, COPD, and CAC
PACS / DICOM Compatible
HIPAA / GDPR
Clinical Overview & Details
Advanced AI-Powered Analysis for Lung Nodules, COPD, and CAC
AVIEW LCS Plus identifies small lung nodules that can develop into lung cancer, and quickly detects damage to the lung parenchyma and calcification of the coronary arteries. It is useful for related examinations and follow-up observations by simultaneously detecting and analyzing chest diseases.
Key Features:
- Automated detection of lung nodules with high accuracy
- Comprehensive COPD phenotype analysis
- Coronary artery calcification scoring (CAC)
- Simultaneous analysis of multiple chest conditions
- Integrated workflow for efficient screening
- Reduces reading time and improves diagnostic confidence
Key Highlights & Benefits
Rapid Automated Processing
Accelerates radiological reading speed while minimizing diagnostic errors.
Subtle Anomaly Detection
Identifies early-stage findings with deep learning neural networks.
Seamless PACS Integration
Integrates directly into hospital workflows without workflow disruption.
Quantitative Metrics
Generates automated volumetric and progression tracking metrics.
Request Live Demonstration
Experience AVIEW LCS Plus with your clinical team. Schedule a custom evaluation.
Technical Specification
Modality
CT / MRI / X-Ray
Deployment
Cloud / On-Premise
Protocol
DICOM 3.0 / HL7
Data Security
End-to-End Encrypted